Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer

被引:111
|
作者
Zou, Peng [1 ,2 ]
Xia, Yiqun [3 ]
Ji, Jiansong [4 ]
Chen, Weiqian [1 ,4 ]
Zhang, Jinsan [1 ]
Chen, Xi [1 ]
Rajamanickam, Vinothkumar [1 ]
Chen, Gaozhi [1 ]
Wang, Zhe [1 ]
Chen, Lingfeng [1 ]
Wang, Yifeng [1 ]
Yang, Shulin [2 ]
Liang, Guang [1 ]
机构
[1] Wenzhou Med Univ, Sch Pharmaceut Sci, Chem Biol Res Ctr, Wenzhou 325035, Zhejiang, Peoples R China
[2] Nanjing Univ Sci & Technol, Sch Environm & Biol Engn, Nanjing 210094, Jiangsu, Peoples R China
[3] Wenzhou Med Univ, Affiliated Hosp 1, Dept Digest Dis, Wenzhou 325035, Zhejiang, Peoples R China
[4] Wenzhou Med Univ, Affiliated Hosp 1, Dept Intervent Radiol, Lishui 323000, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Thioredoxin reductase 1; Reactive oxygen species; Piperlongumine; ER stress; Mitochondrial dysfunction; THIOREDOXIN REDUCTASE 1; REACTIVE OXYGEN; CELL-DEATH; APOPTOSIS; STRESS; ACTIVATION; RESISTANCE; TRASTUZUMAB; GLUTATHIONE; MECHANISMS;
D O I
10.1016/j.canlet.2016.02.058
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Piperlongumine (PL), a natural alkaloid isolated from the fruit of long pepper, is known to selectively kill tumor cells while sparing their normal counterparts. However, the cellular target and potent anticancer efficacy of PL in numerous types of human cancer cells have not been fully defined. We report here that PL may interact with the thioredoxin reductase 1 (TrxR1), an important selenocysteine (Sec) containing antioxidant enzyme, to induce reactive oxygen species (ROS)-mediated apoptosis in human gastric cancer cells. By inhibiting TrxR1 activity and increasing intracellular ROS levels, PL induces a lethal endoplasmic reticulum stress and mitochondrial dysfunction in human gastric cancer cells. Importantly, knockdown of TrxR1 sensitizes cells to PL treatment, and PL displays synergistic lethality with GSH inhibitors (BSO and Erastin) against gastric cancer cells. In vivo, PL treatment markedly reduces the TrxR1 activity and tumor cell burden. Remarkably, TrxR1 was significantly overexpressed in gastric cancer cell lines and human gastric cancer tissues. Targeting TrxR1 with PL thus discloses a previously unrecognized mechanism underlying the biological activity of PL and provides an in-depth insight into the action of PL in the treatment of gastric cancer. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:114 / 126
页数:13
相关论文
共 50 条
  • [41] Withaferin A, a natural thioredoxin reductase 1 (TrxR1) inhibitor, synergistically enhances the antitumor efficacy of sorafenib through ROS-mediated ER stress and DNA damage in hepatocellular carcinoma cells
    Chen, Xi
    Zhu, Ning
    Wu, Yajie
    Zhang, Ye
    Zhang, Yuxuan
    Jin, Kaiwen
    Zhou, Zhiyi
    Chen, Guang
    Wang, Jiabing
    PHYTOMEDICINE, 2024, 128
  • [42] Direct inhibitory effects of gastric cancer against dendritic cells
    Iwauchi, Takehiko
    Tanaka, Hiroaki
    Yoshii, Mami
    Ito, Gentaro
    Kimura, Kenjiro
    Nagahara, Hisashi
    Noda, Eiji
    Amano, Ryosuke
    Kubo, Naoshi
    Muguruma, Kazuya
    Yamada, Nobuya
    Yashiro, Masakazu
    Maeda, Kiyoshi
    Ohira, Masaichi
    Hirakawa, Kosei
    CANCER RESEARCH, 2011, 71
  • [43] Inducing ubiquitination and degradation of TrxR1 protein by LW-216 promotes apoptosis in non-small cell lung cancer via triggering ROS production
    Wang, Runde
    Zhong, Liuyi
    Wang, Tiepeng
    Sun, Tifan
    Yang, Jinming
    Liu, Xinye
    Wu, Yifan
    Guo, Qinglong
    Gao, Yuan
    Zhao, Kai
    NEOPLASIA, 2024, 53
  • [44] Piperlongumine combined with vitamin C as a new adjuvant therapy against gastric cancer regulates the ROS-STAT3 pathway
    Chen, Di
    Wei, Xinyue
    Yang, Ke
    Liu, Xinyue
    Song, Yujin
    Bai, Futing
    Jiang, Yi
    Guo, Yuhang
    Jha, Rajiv Kumar
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2022, 50 (04)
  • [45] TrxR1 and GPx2 are potently induced by isothiocyanates and selenium, and mutually cooperate to protect Caco-2 cells against free radical-mediated cell death
    Barrera, Lawrence N.
    Cassidy, Aedin
    Wang, Wei
    Wei, Taotao
    Belshaw, Nigel J.
    Johnson, Ian T.
    Brigelius-Flohe, Regina
    Bao, Yongping
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2012, 1823 (10): : 1914 - 1924
  • [46] Reduced expression of MUTYH with suppressive activity against mutations caused by 8-hydroxyguanine is a novel predictor of a poor prognosis in human gastric cancer
    Shinmura, Kazuya
    Goto, Masanori
    Suzuki, Masaya
    Tao, Hong
    Yamada, Hidetaka
    Igarashi, Hisaki
    Matsuura, Shun
    Maeda, Matsuyoshi
    Konno, Hiroyuki
    Matsuda, Tomonari
    Sugimura, Haruhiko
    JOURNAL OF PATHOLOGY, 2011, 225 (03): : 414 - 423
  • [47] Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer
    Inoue, Hiroyuki
    Kato, Taigo
    Olugbile, Sope
    Tamura, Kenji
    Chung, Suyoun
    Miyamoto, Takashi
    Matsuo, Yo
    Salgia, Ravi
    Nakamura, Yusuke
    Park, Jae-Hyun
    ONCOTARGET, 2016, 7 (12) : 13621 - 13633
  • [48] Activity of the multikinase inhibitor dasatinib against ovarian cancer cells
    G E Konecny
    R Glas
    J Dering
    K Manivong
    J Qi
    R S Finn
    G R Yang
    K-L Hong
    C Ginther
    B Winterhoff
    G Gao
    J Brugge
    D J Slamon
    British Journal of Cancer, 2009, 101 : 1699 - 1708
  • [49] Activity of the multikinase inhibitor dasatinib against ovarian cancer cells
    Konecny, G. E.
    Glas, R.
    Dering, J.
    Manivong, K.
    Qi, J.
    Finn, R. S.
    Yang, G. R.
    Hong, K-L
    Ginther, C.
    Winterhoff, B.
    Gao, G.
    Brugge, J.
    Slamon, D. J.
    BRITISH JOURNAL OF CANCER, 2009, 101 (10) : 1699 - 1708
  • [50] Anti-Tumor Activity of the Proteasome Inhibitor Bortezomib in Gastric Cancer
    Nakata, Wachiko
    Hayakawa, Yoku
    Nakagawa, Hayato
    Sakamoto, Kei
    Kinoshita, Hiroto
    Takahashi, Ryota
    Hirata, Yoshihiro
    Maeda, Shin
    Koike, Kazuhiko
    GASTROENTEROLOGY, 2011, 140 (05) : S674 - S674